AHA GUIDELINES Bundle (free trial)

Management of Adults With Congenital Heart Disease

AHA GUIDELINES Apps brought to you courtesy of Guideline Central. All of these titles are available for purchase on our website, GuidelineCentral.com. Enjoy!

Issue link: https://eguideline.guidelinecentral.com/i/1541979

Contents of this Issue

Navigation

Page 4 of 93

5 Table 4. ACHD AP Classification (CHD Anatomy + Physiological Stage = ACHD AP Classification) Physiological Stage Stage C BNP or NT-proBNP level ≥2 times the upper limit of normal Hemodynamically significant shunt* Mild or moderate chronic hypoxemia* (baseline resting oxygen saturation 86–92%) Moderate or greater valvular dysfunction* Moderate or severe ventricular dysfunction (systemic, pulmonic, or both) Pulmonary arterial hypertension (low-risk)* Sustained or high-burden tachyarrhythmia in the past 12 months requiring treatment with antiarrhythmic drugs, ablation, cardioversion, or ICD therapy Stage D Hospitalization for heart failure in the past 12 months Endocarditis in the prior 1 year Eisenmenger syndrome NYHA functional class* III or IV symptoms Recurrent arrhythmias* that are hemodynamically significant and/or refractory to treatment Severe hypoxemia* (baseline oxygen saturation ≤85%) Pulmonary arterial hypertension* (intermediate- or high-risk) Modified with permission from Stout et al. Copyright © 2018 American Heart Association, Inc. and American College of Cardiolog y Foundation. * See Table 5. ACHD indicates adult congenital heart disease; AP, anatomic and physiological; ASD, atrial septal defect; BNP, B-type natriuretic peptide; ICD, implantable cardioverter-defibrillator; NT-proBNP, N-terminal prohormone of B-type natriuretic peptide; NYHA, New York Heart Association; PDA, patent ductus arteriosus; TGA, transposition of the great arteries; and VSD, ventricular septal defect. (cont'd)

Articles in this issue

Archives of this issue

view archives of AHA GUIDELINES Bundle (free trial) - Management of Adults With Congenital Heart Disease